TipRanks
55% OFF
PC:ACCRO

Accropeutics Inc

Accropeutics Inc. is a clinical-stage biotechnology company focused on developing innovative therapeutics that target molecular mechanisms of regulated cell death. Their aim is to address immune-mediated diseases, leveraging cutting-edge research to create novel treatment options.

Leadership & Board

Latest Estimated Valuation

Estimated Valuation
―
Total Amount Raised
$12M
Total Funding Rounds
1
Latest Funding Amount
$12M
Latest Funding Round
Series B
Post-Money Valuation
―

Funding Round

Funding DateFunding RoundAmount RaisedPost-Money Valuation
Mar 14, 2025Series B$12.00M―

Investors

Similar Companies

A snapshot of private companies similar to Accropeutics Inc, helping you discover and navigate related company profiles.

Related News and Analysis